Physical activity during daily life and mortality in patients with peripheral arterial disease.

PubWeight™: 2.02‹?› | Rank: Top 2%

🔗 View Article (PMC 2645622)

Published in Circulation on July 03, 2006

Authors

Parveen K Garg1, Lu Tian, Michael H Criqui, Kiang Liu, Luigi Ferrucci, Jack M Guralnik, Jin Tan, Mary M McDermott

Author Affiliations

1: New York University School of Medicine, New York City, NY, USA.

Associated clinical trials:

Effects of Different Protocols of Physical Training on Levels of Muscle Strength and Functional Capacity | NCT03092336

Articles citing this

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA (2009) 3.83

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol (2008) 1.82

Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol (2007) 1.67

Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg (2007) 1.47

Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg (2008) 1.36

Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation (2011) 1.27

Low lifetime recreational activity is a risk factor for peripheral arterial disease. J Vasc Surg (2011) 1.18

Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol (2011) 1.14

Effects of posture on shear rates in human brachial and superficial femoral arteries. Am J Physiol Heart Circ Physiol (2008) 1.13

Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation (2008) 1.12

Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease. Circulation (2009) 1.12

Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol (2007) 1.09

Training-induced vascular adaptations to ischemic muscle. J Physiol Pharmacol (2008) 1.07

Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study. J Am Coll Cardiol (2012) 1.04

Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg (2008) 1.01

Baseline lower extremity strength and subsequent decline in functional performance at 6-year follow-up in persons with lower extremity peripheral arterial disease. J Am Geriatr Soc (2009) 1.00

Gender differences in daily ambulatory activity patterns in patients with intermittent claudication. J Vasc Surg (2010) 0.98

Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc (2008) 0.94

Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vasc Med (2009) 0.94

Multimodality imaging approach for serial assessment of regional changes in lower extremity arteriogenesis and tissue perfusion in a porcine model of peripheral arterial disease. Circ Cardiovasc Imaging (2013) 0.93

Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial. J Am Heart Assoc (2014) 0.92

Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease. J Vasc Surg (2007) 0.92

Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease. Am J Cardiol (2008) 0.92

Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study. Circ Heart Fail (2009) 0.90

Superficial femoral artery plaque and functional performance in peripheral arterial disease: walking and leg circulation study (WALCS III). JACC Cardiovasc Imaging (2011) 0.88

Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res (2015) 0.87

Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults. Arterioscler Thromb Vasc Biol (2014) 0.86

Leg strength predicts mortality in men but not in women with peripheral arterial disease. J Vasc Surg (2010) 0.84

Association between daily ambulatory activity patterns and exercise performance in patients with intermittent claudication. J Vasc Surg (2008) 0.81

The effects of smoking status on walking ability and health-related quality of life in patients with peripheral arterial disease. J Cardiovasc Nurs (2013) 0.80

Effect of in-hospital physical activity on cardiovascular prognosis in lower extremity bypass for claudication. J Phys Ther Sci (2015) 0.78

Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects. Redox Biol (2017) 0.77

Associations of Accelerometry-Assessed and Self-Reported Physical Activity and Sedentary Behavior With All-Cause and Cardiovascular Mortality Among US Adults. Am J Epidemiol (2016) 0.77

Comparison between subjective and objective methods to assess functional capacity during clinical treatment in patients with intermittent claudication. Einstein (Sao Paulo) (2013) 0.75

Association of 6-Minute Walk Performance and Physical Activity With Incident Ischemic Heart Disease Events and Stroke in Peripheral Artery Disease. J Am Heart Assoc (2015) 0.75

Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database). Am J Cardiol (2014) 0.75

Management of peripheral arterial disease in the elderly: focus on cilostazol. Clin Interv Aging (2008) 0.75

Efficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial. BMC Public Health (2016) 0.75

Accelerometry-Assessed Latent Class Patterns of Physical Activity and Sedentary Behavior With Mortality. Am J Prev Med (2017) 0.75

Articles cited by this

Enzymatic determination of total serum cholesterol. Clin Chem (1974) 20.65

Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65

Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med (1986) 11.17

Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med (1992) 8.94

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J (1985) 8.06

All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work. Arch Intern Med (2000) 5.51

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA (2004) 4.27

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA (2001) 3.90

Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA (1995) 3.57

Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg (2000) 3.33

The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med (2002) 3.32

Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem (1995) 3.20

The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med (1996) 2.85

The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc (1998) 2.53

Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation (1995) 2.47

Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA (1993) 2.28

Natural history of leisure-time physical activity and its correlates: associations with mortality from all causes and cardiovascular disease over 28 years. Am J Epidemiol (1996) 2.24

Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure. Biometrics (2001) 2.23

Comparison of activity levels using the Caltrac accelerometer and five questionnaires. Med Sci Sports Exerc (1994) 1.97

Physical activity and all cause mortality in women: a review of the evidence. Br J Sports Med (2002) 1.87

The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease. Vasc Med (1997) 1.62

Measuring physical activity in peripheral arterial disease: a comparison of two physical activity questionnaires with an accelerometer. Angiology (2000) 1.57

Change in lifestyle factors and their influence on health status and all-cause mortality. Int J Epidemiol (1999) 1.46

Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication. J Am Geriatr Soc (2001) 1.46

Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice*. J Gen Intern Med (2001) 1.45

The Caltrac accelerometer as a physical activity monitor for school-age children. Med Sci Sports Exerc (1990) 1.38

Characteristics of leisure time physical activity associated with decreased risk of premature all-cause and cardiovascular disease mortality in middle-aged men. Am J Epidemiol (1996) 1.33

The ankle brachial index independently predicts walking velocity and walking endurance in peripheral arterial disease. J Am Geriatr Soc (1998) 1.17

Ability of the Caltrac accelerometer to assess daily physical activity levels. J Cardiopulm Rehabil (1996) 1.12

Exercise, body mass index, caloric intake, and cardiovascular mortality. Am J Prev Med (2003) 1.10

Exercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment. Curr Drug Targets Cardiovasc Haematol Disord (2004) 1.07

Work and leisure time physical activity and mortality in men and women from a general population sample. Ann Epidemiol (1999) 1.06

Peripheral arterial disease rehabilitation: a review. J Cardiopulm Rehabil (2003) 0.97

Energy expenditure estimates of the Caltrac accelerometer for running, race walking, and stepping. Br J Sports Med (1997) 0.87

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88

Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66

Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Gait speed and survival in older adults. JAMA (2011) 15.01

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci (2004) 12.46

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18

Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet (2010) 8.74

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci (2006) 8.00

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Patterns of functional decline at the end of life. JAMA (2003) 7.79

Physical performance measures in the clinical setting. J Am Geriatr Soc (2003) 7.67

Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49

Objectively measured sleep characteristics among early-middle-aged adults: the CARDIA study. Am J Epidemiol (2006) 7.49

Decline in physical activity in black girls and white girls during adolescence. N Engl J Med (2002) 7.06

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet (2013) 7.03

Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc (2006) 6.81

Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2005) 6.80

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci (2006) 6.61

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation (2003) 6.13

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst (2006) 6.02

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood (2004) 5.86

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med (2008) 5.86

Self-reported and measured sleep duration: how similar are they? Epidemiology (2008) 5.81

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc (2004) 5.80

Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) (2003) 5.73

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA (2012) 5.41

Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med (2010) 5.20

The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 5.05

Frailty: an emerging research and clinical paradigm--issues and controversies. J Gerontol A Biol Sci Med Sci (2007) 4.98

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87

A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet (2008) 4.75

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet (2008) 4.69

Relation between the changes in physical activity and body-mass index during adolescence: a multicentre longitudinal study. Lancet (2005) 4.65

Hearing loss and incident dementia. Arch Neurol (2011) 4.65

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation (2003) 4.52

Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol (2004) 4.43

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA (2004) 4.27

Hearing loss and cognitive decline in older adults. JAMA Intern Med (2013) 4.25

Hearing loss prevalence in the United States. Arch Intern Med (2011) 4.22

Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA (2009) 4.18

The origins of age-related proinflammatory state. Blood (2004) 4.15

Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.10

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA (2011) 4.09

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA (2003) 4.07

Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2004) 3.96

Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (2002) 3.88

Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA (2009) 3.83

Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med (2005) 3.81

Genomewide nonadditive gene regulation in Arabidopsis allotetraploids. Genetics (2005) 3.78

Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med (2008) 3.76

Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76

Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75

Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med (2009) 3.71